Home LiteratureArticle Details
PMID: 3591453 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction.

Acta medica Scandinavica ·Vol. 221 ·No. 2 ·1987-00-00 ·Pages 149-53

Gram J, Jespersen J, Kluft C, Rijken DC

Abstract

In a prospective study selected fibrinolysis variables were assessed in plasma samples from 29 consecutive patients recovering a first instance of acute myocardial infarction and the results were correlated with reinfarction during the next four years. Nine patients suffered a reinfarction leaving a group of 20 patients without evidence of relapse. The reinfarction group was characterized by lower tissue plasminogen activator activities in plasma euglobulins (p less than 0.05), significantly higher plasma concentrations of tissue plasminogen activator antigen (p less than 0.002) and a tendency to a higher plasma level of plasminogen activator inhibition capacity. There were no significant differences between the groups in plasma concentrations of plasminogen, histidine-rich glycoprotein, plasminogen kringle-4-binding-protein, and alpha 2-antiplasmin.

MeSH Terms
Fibrinolysis Follow-Up Studies Humans Myocardial Infarction/blood Plasminogen Activators/blood Prospective Studies Recurrence Risk
Chemicals
Plasminogen Activators
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Gram J
Jespersen J
Kluft C
Rijken D C
Article Info
Journal
Acta medica Scandinavica
Abbr.
Acta Med Scand
ISSN
0001-6101
Published
1987-00-00
Pages
149-53
Language
English
Region
Sweden
NLM ID
0370330
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com